Kolexia
Gabellier Ludovic Hématologie
Gabellier Ludovic
Hématologie
Hôpital Saint-Éloi
Montpellier, France
48 Activités
7 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Lymphomes Leucémie-lymphome lymphoblastique à précurseurs B et T Maladie de Hodgkin Vascularite Chromosome Philadelphie Sarcomes

Collaborateurs

Voir plus
Cartron Guillaume
Cartron Guillaume
Hôpital Saint-Éloi, Montpellier, France
Ceballos Patrice
Ceballos Patrice
Hôpital Lapeyronie, Montpellier, France
Tudesq Jean-Jacques
Tudesq Jean-Jacques
Hôpital Saint-Éloi, Montpellier, France
Vincent Laure
Vincent Laure
Hôpital Saint-Éloi, Montpellier, France

Industries

Voir plus
Janssen
3 collaboration(s)
Dernière en 2023
IQVIA
2 collaboration(s)
Dernière en 2021
P\S\L Group Services
2 collaboration(s)
Dernière en 2021
Novartis
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Annals of hematology   26 janvier 2024
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.
European journal of haematology   02 novembre 2023
Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression
65th ASH Annual Meeting Abstracts   02 novembre 2023
Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias.
Nucleic acids research   11 septembre 2023
SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacitidine in preclinical models of acute myeloid leukemia.
Haematologica   24 août 2023
Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study.
British journal of haematology   04 juillet 2023
Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis.
Journal of translational autoimmunity   11 février 2023
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias.
Haematologica   01 novembre 2022